Quick Answer
REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Stockholders Equity of $8.65 million for fiscal year 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $8.65M | +964.2% |
| 2024 | $812.6K | -85.8% |
| 2023 | $5.72M | +144.6% |
| 2023 | -$12.81M | -605.7% |
| 2023 | -$1.82M | -212.5% |
| 2023 | $1.61M | -80.8% |
| 2022 | $8.39M | -52.2% |
| 2022 | $17.56M | -38.8% |
| 2021 | $28.69M | +424.8% |
| 2020 | $5.47M | +9.3% |
| 2020 | $5.00M | +173.4% |
| 2019 | -$6.81M | -236.2% |
| 2019 | $5.00M | +183.8% |
| 2018 | -$5.96M | — |
| 2018 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.55M | +145.6% | +1090.9% |
| June 30, 2025 | -$459.1K | +92.4% | +89.7% |
| March 31, 2025 | -$4.46M | -231.4% | -648.9% |
| December 31, 2024 | $812.6K | -85.8% | +108.1% |
| September 30, 2024 | -$9.98M | +22.1% | -65.2% |
| June 30, 2024 | -$6.04M | -232.8% | -348.9% |
| March 31, 2024 | -$1.35M | -183.4% | -123.5% |
| December 31, 2023 | $5.72M | -31.9% | +144.6% |
- REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +964.2% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from REVIVA PHARMACEUTICALS HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: